Practitioners
Patients
WEBINAR
Join our live CPD webinar for practical insights into how pharmacogenomics (PGx) can support safer, more personalised mental health prescribing—especially in patients with ADHD and those on complex medication regimens.
22nd July 2025
Time: 12:30pm
Duration: 45 mins
Audience
Physiatrist
Mental Health Practitioners
For mental health professionals, managing patients on multiple medications—such as antidepressants, antipsychotics, and ADHD treatments—requires careful navigation of drug-drug interactions (DDIs). These can reduce efficacy, cause toxicity, or lead to unpredictable side effects.
This advanced CPD webinar explores how PGx testing helps clinicians understand how metabolic enzymes (e.g., CYP2D6, CYP3A4) affect drug processing, providing tools to reduce adverse drug reactions and personalise treatment in psychiatry and neurodevelopmental care.
Whether you're treating ADHD, anxiety, or mood disorders, this session will help you apply pharmacogenomic insights in real-world clinical settings.
Learn how polypharmacy in mental health can increase DDI risks and adverse drug outcomes.
Explore how PGx guides safer prescribing across multiple genetically influenced enzymatic pathways.
Review case studies from psychiatry and ADHD management with practical applications.
Understand how to individualise treatment based on metabolism, drug transport, and patient genetics.
Bring your questions—our experts will answer them live during the session.
Receive a certificate of attendance for your CPD portfolio.
Join our live CPD webinar for practical insights into how pharmacogenomics (PGx) can support safer, more personalised mental health prescribing—especially in patients with ADHD and those on complex medication regimens.